What is the clinical evidence from this study?

Study design: Cross-Sectional. Population: Cardio-renal-metabolic multimorbidity (CRMM) (n=11017). Intervention: Socio-demographic factors. Primary outcome: Prevalence of cardio-renal-metabolic multimorbidity (CRMM) (95% CI 32.7-34.5).

What does this research mean for the field?

Cardio-renal-metabolic multimorbidity affects approximately one-third (33.6%) of adults in India, with significantly higher prevalence among males, older adults, urban residents, and individuals in higher wealth quintiles. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To assess the prevalence of cardio-renal-metabolic multimorbidity in India among adults aged 30 and above.

June 7, 2026Diabetes

Cardio-renal-metabolic multimorbidity affects ~34% of Indian adults over 30, particularly older urban males.

View Full Paper

Ask AI

Bookmark

Why the study?

Cardio-renal-metabolic multimorbidity comprises conditions with shared risk factors and management strategies, but data on its prevalence in India are limited.

Population

11017 adults aged ≥ 30 years in North and South India

Design

Representative community-based study

Key result

The overall prevalence of cardio-renal-metabolic multimorbidity among adults aged ≥30 years in India was 33.6% (95% CI 32.7-34.5), with higher rates in males, urban residents, and older adults.

Authors

SMSAILESH MOHAN NVNikhil Srinivasapura Venkateshmurthy MSM SWATHI SHENOY

Discussion

Member takes

Overview

Indicates substantial CRMM burden among Indian adults; leaves open optimal integrated strategies pending prospective data.

Key Points

To assess the prevalence of cardio-renal-metabolic multimorbidity in India among adults aged 30 and above.
Conducted a large community-based study with 11017 adults in North and South India.
Administered questionnaires and measured blood pressure, height, weight, and fasting blood samples.
Defined cardio-renal-metabolic multimorbidity as the presence of two or more chronic conditions.
Overall cardio-renal-metabolic multimorbidity prevalence was 33.6% (95% CI: 32.7-34.5).
Prevalence was higher among males (37.7% (36.4-39.0)) and those in urban areas (42.9% (41.6-44.3)).
Among individuals aged ≥ 60 years, prevalence reached 49.7% (47.8-51.7) and was 44.3% (42.1-46.6) in the highest wealth quintile.

Study Design

Type

Cross-Sectional (n=11,017)

Multicenter

Yes

Structured PICO

Population

11,017 adults aged ≥ 30 years in North and South India assessed for the prevalence of cardio-renal-metabolic multimorbidity.

Outcome

Overall prevalence of cardio-renal-metabolic multimorbidity (CRMM) and stratified by age, gender, residence, and wealth index

Cardio-renal-metabolic multimorbidity affects approximately one-third of adults aged ≥30 years in India, highlighting a significant burden that requires integrated primary care interventions.

Cite This Study

MOHAN et al. (2026) conducted a cross-sectional in Cardio-renal-metabolic multimorbidity (CRMM) (n=11,017). Socio-demographic factors was evaluated on Prevalence of cardio-renal-metabolic multimorbidity (CRMM) (95% CI 32.7-34.5). The overall prevalence of cardio-renal-metabolic multimorbidity among adults aged ≥30 years in India was 33.6% (95% CI 32.7-34.5), with higher rates in males, urban residents, and older adults.

synapsesocial.com/papers/6a250c027def13d035e1c17e https://doi.org/10.2337/db26-2185-p

View Full Paper

Ask AI

Bookmark

June 7, 2026Diabetes

Cardio-renal-metabolic multimorbidity affects ~34% of Indian adults over 30, particularly older urban males.

View Full Paper

Ask AI

Bookmark

Why the study?

Cardio-renal-metabolic multimorbidity comprises conditions with shared risk factors and management strategies, but data on its prevalence in India are limited.

Population

11017 adults aged ≥ 30 years in North and South India

Design

Representative community-based study

Key result

The overall prevalence of cardio-renal-metabolic multimorbidity among adults aged ≥30 years in India was 33.6% (95% CI 32.7-34.5), with higher rates in males, urban residents, and older adults.

Authors

SMSAILESH MOHAN NVNikhil Srinivasapura Venkateshmurthy MSM SWATHI SHENOY

Discussion

Member takes

Overview

Indicates substantial CRMM burden among Indian adults; leaves open optimal integrated strategies pending prospective data.

Key Points

To assess the prevalence of cardio-renal-metabolic multimorbidity in India among adults aged 30 and above.
Conducted a large community-based study with 11017 adults in North and South India.
Administered questionnaires and measured blood pressure, height, weight, and fasting blood samples.
Defined cardio-renal-metabolic multimorbidity as the presence of two or more chronic conditions.
Overall cardio-renal-metabolic multimorbidity prevalence was 33.6% (95% CI: 32.7-34.5).
Prevalence was higher among males (37.7% (36.4-39.0)) and those in urban areas (42.9% (41.6-44.3)).
Among individuals aged ≥ 60 years, prevalence reached 49.7% (47.8-51.7) and was 44.3% (42.1-46.6) in the highest wealth quintile.

Study Design

Type

Cross-Sectional (n=11,017)

Multicenter

Yes

Structured PICO

Population

11,017 adults aged ≥ 30 years in North and South India assessed for the prevalence of cardio-renal-metabolic multimorbidity.

Outcome

Overall prevalence of cardio-renal-metabolic multimorbidity (CRMM) and stratified by age, gender, residence, and wealth index

Cardio-renal-metabolic multimorbidity affects approximately one-third of adults aged ≥30 years in India, highlighting a significant burden that requires integrated primary care interventions.

Cite This Study

synapsesocial.com/papers/6a250c027def13d035e1c17e https://doi.org/10.2337/db26-2185-p

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark